13.11BMarket Cap
28.37P/E TTM
Medpace Holdings Inc's Company Valuation
Currency: USD Updated: 2026-06-18The current valuation score of Medpace Holdings Inc is 9.87, ranking 9 out of 389 in the Biotechnology & Medical Research industry. Its current P/E ratio is 28.37, which is 58.38% below the recent high of 44.93 and 27.65% above the recent low of 20.52.

Relevant data have not been disclosed by the company yet.

Relevant data have not been disclosed by the company yet.

Relevant data have not been disclosed by the company yet.

Relevant data have not been disclosed by the company yet.